About Baudax Bio
Baudax Bio is a company based in Chester (United States) founded in 2015. It operates as a B2B. The company has 80 employees as of December 31, 2021. Baudax Bio has completed 1 acquisition, including TeraImmune. Baudax Bio operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Chester, United States
- Employees 80 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Baudax Bio, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
80
as on Dec 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Baudax Bio
Baudax Bio is a publicly listed company on the OTC with ticker symbol BXRXQ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Baudax Bio
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Baudax Bio
Investments & Acquisitions by Baudax Bio
Baudax Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TeraImmune.
Investment portfolio details for Baudax Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
T-cell therapies for treating various diseases are developed by TeraImmune.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Baudax Bio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Baudax Bio
Detailed financials for Baudax Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Baudax Bio Comparisons
Peer comparison for Baudax Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Baudax Bio
Baudax Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| Locked | Locked | Locked |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| Locked | Locked | Locked |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| Locked | Locked | Locked |
Therapies for pain and addiction treatment are developed.
|
|
| Locked | Locked | Locked |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| Locked | Locked | Locked |
Pain treatment products are developed through reformulation technologies.
|
Detailed competitors of Baudax Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Baudax Bio
Complete news archive for Baudax Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Baudax Bio
Baudax Bio was founded in 2015 and raised its 1st funding round 6 years after it was founded.
Baudax Bio is headquartered in Chester, United States. It is registered at Chester, Pennsylvania, United States.
As of Dec 31, 2021, the latest employee count at Baudax Bio is 80.
Baudax Bio develops innovative technologies for acute pain treatment in healthcare through providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and pain management. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Baudax Bio's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
Yes, Baudax Bio is publicly traded on OTC under the ticker symbol BXRXQ.
Baudax Bio has made 1 acquisition, including TeraImmune.
The ticker symbol of Baudax Bio is BXRXQ on OTC.